person

Evert-Jan D. K.

Country
The Netherlands
Department
Hematology

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
5
Sites with multiple studies

Has run more than one trial at 5 of 111 partner sites.

Specializations

Thrombosis Research

The investigator specializes in the management of venous thromboembolism (VTE), with particular emphasis on cancer-associated thrombotic conditions. Their research interests focus on exploring innovative therapeutic approaches for preventing recurrent VTE in oncology patients.

  • Cancer-Associated Thrombosis
  • Anticoagulation Therapy
  • Thrombosis Prevention

Their expertise extends to comparative evaluation of anticoagulant treatments for managing thrombotic complications in cancer patients.

Oncology Care

The investigator focuses on optimizing treatment strategies for cancer patients with thromboembolic complications. Their work involves evaluating therapeutic approaches that address both oncological and thrombotic concerns in complex patient cases.

  • Cancer-Related Complications
  • Supportive Cancer Care
  • Risk Management

Their research encompasses the intersection of cancer care and thrombosis management, addressing the specific needs of this patient population.

Clinical Outcomes

The investigator's work centers on evaluating therapeutic efficacy and safety profiles of various treatment approaches. Their research emphasizes comparative assessment of different anticoagulation strategies in specialized patient populations.

  • Treatment Effectiveness
  • Safety Assessment
  • Patient Outcomes

Their research contributes to understanding optimal treatment strategies for complex medical conditions involving both cancer and thrombosis.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.